The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury.
about
Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptorsCilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusionThiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cellsProtective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of actionPioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.Signal transduction involved in lipoxin A4‑induced protection of tubular epithelial cells against hypoxia/reoxygenation injury.Ameliorating the Effect of Pioglitazone on LPS-Induced Inflammation of Human Oligodendrocyte Progenitor Cells.BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1.Podocyte NF-κB is dispensable for the pathogenesis of renal ischemia-reperfusion injury.Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes.Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition.Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
P2860
Q24305523-C0E916EC-75CD-40EC-9425-54EC4AA1C442Q28538659-FE121F01-546F-4F20-B9AA-C8FC2A06DA56Q36158956-F84CEADF-E36F-49AC-BF10-55283CC44812Q36254033-9D7B900A-A992-4823-B4F1-93EAB4896319Q36864663-A2D6F7FE-DF98-4336-88D6-05077DADEB21Q37590946-26BA02DD-2A98-4CDF-BE06-D6750D3AC22AQ37720277-3B5D2747-E0AA-42AB-AB29-1FAADA6CB34BQ38795053-37214951-7B4A-4BB5-A3EB-F5925D85DF69Q38817418-9FEE3E93-0053-440D-842A-C0B6C83A22E9Q40964714-8410E597-2D0E-4290-914C-0E4E0AAE1CA3Q42500072-CC7CD731-5FE6-4118-8479-260C5F2450E0Q51146865-CE2D2565-3D08-47E2-AEE4-E996314A226EQ54296720-1E64432B-1CC1-4CE3-BD84-025A8AC79F31
P2860
The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The subtypes of peroxisome pro ...... in decreasing podocyte injury.
@en
type
label
The subtypes of peroxisome pro ...... in decreasing podocyte injury.
@en
prefLabel
The subtypes of peroxisome pro ...... in decreasing podocyte injury.
@en
P2093
P2860
P50
P1476
The subtypes of peroxisome pro ...... in decreasing podocyte injury
@en
P2093
Gianluca Miglio
Lorenza Rattazzi
Massimo Collino
P2860
P304
P356
10.1111/J.1476-5381.2010.01032.X
P407
P577
2011-01-01T00:00:00Z